Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome.

Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome.

Item
http://www.wikidata.org/entity/Q41849079
Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis.Mirroring the CANTOS revolution: is anti-inflammatory therapy for diabetes just around the corner?Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study.Effect of a selective SGLT2 inhibitor, luseogliflozin, on circadian rhythm of sympathetic nervous function and locomotor activities in metabolic syndrome rats.Cardioprotective anti-hyperglycaemic medications: a review of clinical trials.Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects.Role of the sodium-hydrogen exchanger in mediating the renal effects of drugs commonly used in the treatment of type 2 diabetes.Mechanistic Insights of Empagliflozin-Mediated Cardiac Benefits: Nearing the Starting Line : Editorial to: "Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes" by N. Hammoudi et al.Un-sweetening the Heart: Possible pleiotropic effects of SGLT2 inhibitors on cardio and cerebrovascular alterations in resistant hypertensive subjects.Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes.Dual inhibition of sodium–glucose linked cotransporters 1 and 2 exacerbates cardiac dysfunction following experimental myocardial infarction.
P2860

Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome.

Item
http://www.wikidata.org/entity/Q41849079
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Empagliflozin lessened cardiac ...... rats with metabolic syndrome.
@en
type
label
Empagliflozin lessened cardiac ...... rats with metabolic syndrome.
@en
prefLabel
Empagliflozin lessened cardiac ...... rats with metabolic syndrome.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P6179
P698
P921
P932
P356
P1433
P1476
Empagliflozin lessened cardiac ...... rats with metabolic syndrome.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P6179
P698
P921
P932